Unknown Author
January 23, 2026
Kirkland Advises Linden Capital Partners on Minority Investment from Blue Owl's GP Strategic Capital Platform and Lunate

1 min
AI-made summary
- Kirkland & Ellis represented Linden Capital Partners, a Chicago-based healthcare private equity firm, in a passive, minority investment from Blue Owl's GP Strategic Capital platform and Lunate Capital through their joint venture
- The investment aims to support Linden's growth and strategic initiatives by providing additional balance sheet flexibility
- The terms of the transaction were not disclosed
- The Kirkland team included several corporate and tax partners and associates.
Kirkland & Ellis advised Linden Capital Partners, a Chicago-based healthcare private equity firm, in connection with a passive, minority investment in its business from Blue Owl's GP Strategic Capital platform and Lunate Capital via their joint venture. The passive minority investment supports the continued growth of Linden's investment platform and development of strategic initiatives by bringing additional flexibility to the firm's balance sheet. Terms of the transaction were not disclosed. Read Linden’s press release The Kirkland team was led by corporate partners Michael Reeves, Daniel Lavon-Krein, James Mayne and Robert Wilson, and included corporate associate Ethan Green and tax partners Daniel Meehan and Christopher Odell.
Article Author
Unknown Author
The Sponsor
